Compare Crispr Therapeutics AG (CRSP) vs Illinois Tool Works Inc. (ITW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Illinois Tool Works Inc. — how do they compare? Crispr Therapeutics AG trades at $54.31 (market cap $5.23B), while Illinois Tool Works Inc. trades at $293.7 (market cap $83.49B). The key difference: Illinois Tool Works Inc. is far larger — about 16× Crispr Therapeutics AG's market cap, and Illinois Tool Works Inc. pays a 2.35% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | ITW | |
|---|---|---|
Market Cap | $5.23B | $83.49B |
Sector | Health | Industrials |
52-Week High | $76.78 | $299.60 |
52-Week Low | $44.34 | $241.07 |
Enterprise Value | $3.65B | $92.34B |
Dividend Yield | — | 2.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →
